A Study of MLN8054 in Patients With Advanced Solid Tumors

Status Terminated

Clinical Trial Summary

The purpose of this study is to determine (1) The side effects or toxicities of MLN8054;(2) The highest dose where side effects or toxicities are not too severe; (3) How MLN8054 is absorbed into the general blood circulation and eliminated from the body; and (4) The levels of MLN8054 in the blood that are needed to inhibit Aurora A kinase.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00249301
Study type	Interventional
Source	Millennium Pharmaceuticals, Inc.
Contact
Status	Terminated
Phase	Phase 1
Start date	October 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03273426` - Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.	N/A
Recruiting	`NCT04583124` - Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)	N/A
Active, not recruiting	`NCT04489173` - TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer	Phase 2
Recruiting	`NCT02913573` - Effect of Pectoral Nerve Block on Post-op Pain in Patients Undergoing Mastectomy and Immediate Reconstruction	Phase 2
Completed	`NCT03124095` - Combined Training Intervention for Women Who Underwent Primary Treatment for Breast Cancer	N/A
Terminated	`NCT00251095` - Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer	Phase 3
Completed	`NCT05576545` - Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment	N/A
Active, not recruiting	`NCT03625635` - Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment	N/A
Recruiting	`NCT04799535` - Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Withdrawn	`NCT03266562` - Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography	N/A
Completed	`NCT00530868` - Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer	Phase 2
Recruiting	`NCT06255808` - Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor
Completed	`NCT04640220` - Improvement of Range of Motion in Frozen Shoulder in Breast Cancer Survivors	N/A
Completed	`NCT02970682` - SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer	Phase 2
Completed	`NCT02316561` - Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer	N/A
Terminated	`NCT00638963` - Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)	Phase 2
Not yet recruiting	`NCT06056414` - Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation	N/A
Recruiting	`NCT05427071` - Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy	N/A
Recruiting	`NCT03740893` - PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition and/or Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Chemotherapy Resistant Residual Triple Negative Breast Cancer	Phase 2
Active, not recruiting	`NCT03935282` - Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors	N/A